Dale G. Ando
2015
In 2015, Dale G. Ando earned a total compensation of $1.1M as Vice President, Therapeutic Development and Chief Medical Officer at Sangamo Biosciences, a 18% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $135,450 |
|---|---|
| Option Awards | $271,400 |
| Salary | $450,000 |
| Stock Awards | $235,250 |
| Total | $1,092,100 |
Ando received $450K in salary, accounting for 41% of the total pay in 2015.
Ando also received $135.5K in non-equity incentive plan, $271.4K in option awards and $235.3K in stock awards.
Rankings
In 2015, Dale G. Ando's compensation ranked 7,530th out of 13,638 executives tracked by ExecPay. In other words, Ando earned more than 44.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,530 out of 13,638 | 45th |
Division Manufacturing | 2,845 out of 5,187 | 45th |
Major group Chemicals And Allied Products | 1,031 out of 1,857 | 45th |
Industry group Drugs | 831 out of 1,531 | 46th |
Industry Biological Products, Except Diagnostic Substances | 144 out of 260 | 45th |
Source: SEC filing on April 25, 2016.
Ando's colleagues
We found four more compensation records of executives who worked with Dale G. Ando at Sangamo Biosciences in 2015.